Clinical Trial Update: Effects of Nattokinase on Cardiovascular Risk, Gut Microbiota, Sleep, and Cognition in Metabolic Syndrome With Sleep Disorders. [NA]

View source ↗

Summary

A clinical trial evaluating nattokinase effects on cardiovascular risk, gut microbiota, sleep, and cognition in individuals with metabolic syndrome and sleep di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Sleep Disorders

Drugs mentioned

• Nattokinase (Nattokinase)

Snippet

Sponsor: Taipei Medical University | Conditions: Metabolic Syndrome, Sleeping Disorders | NA | Status: RECRUITING